NTRA - Natera wins court order barring NeoGenomics from selling RaDaR assay
2023-12-28 06:48:40 ET
More on Natera
- Natera: Squeezing The Last Drop From NIPT Growth Engine
- Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript
- Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Merck to use Natera's database for oncology drug research
- Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant
For further details see:
Natera wins court order barring NeoGenomics from selling RaDaR assay